Author:
Simone Giovanni,Diotaiuti Sergio,Digennaro Maria,Sambiasi Domenico,De Summa Simona,Tommasi Stefania,Altieri Rosanna,Mangia Annita,Dantona Caterina,Paradiso Angelo
Publisher
Springer Science and Business Media LLC
Reference10 articles.
1. Campbell EJ, Tesson M, Doogan F, Mohammed ZM, Mallon E, Edwards J (2016) The combined endocrine receptor in breast cancer, a novel approach to traditional hormone receptor interpretation and a better discriminator of outcome than ER and PR alone. Br J Cancer 115 (8): 967–973.
2. Esber N, Cherbonnier C, Resche-Rigon M, Hamze A, Alami M, Fagart J, Loosfelt H, Lombès M, Chabbert-Buffet N (2016) Anti-tumoral effects of anti-progestins in a patient-derived breast cancer xenograft model. Horm Cancer 7 (2): 137–147.
3. Lim E, Palmieri C, Tilley WD (2016) Renewed interest in the progesterone receptor in breast cancer. Br J Cancer 115 (8): 909–911.
4. Lim TH, Lim AS, Thike AA, Tien SL, Tan PH (2016) Implications of the Updated 2013 American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations on Human Epidermal Growth Factor Receptor 2 Gene Testing Using Immunohistochemistry and Fluorescence In Situ Hybridization for Breast Cancer. Arch Pathol Lab Med 140 (2): 140–147.
5. Lyman GH, Somerfield MR, Bosserman LD, Perkins CL, Weaver DL, Giuliano AE (2016) Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol epub ahead of print 12 December 2016.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献